Immunoassay for serum cadmium: A new tool to assess risk for pancreatic cancer.

被引：0
|
作者：
Blake, DA
Kriegel, AM
Soliman, A
机构：
[1] Tulane Univ, Sch Med, New Orleans, LA 70112 USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2003年 / 225卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
0002-BTEC
引用
收藏
页码：U44 / U44
页数：1
相关论文
共 50 条
  • [41] Serum one-carbon metabolism factors and risk of colorectal cancer.
    Weinstein, S. J.
    Albanes, D.
    Selhub, J.
    Stolzenberg-Solomon, R.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007, 165 (11) : S132 - S132
  • [42] Qualitative flow metabolic phenotype of pancreatic cancer. A new prognostic biomarker?
    Riviere, Deniece
    Aarntzen, Erik
    van Geenen, Erwin
    Chang, David
    de Geus-Oei, Lioe-Fee
    Brosens, Lodewijk
    van Laarhoven, Kees
    Gotthardt, Martin
    Hermans, John
    HPB, 2024, 26 (03) : 389 - 399
  • [43] PS-341: A new agent with activity in prostate and pancreatic cancer.
    Bruns, C
    Harbison, MT
    Bold, RJ
    Elliott, P
    Adams, J
    Abbruzzese, J
    Pettaway, C
    McConkey, DJ
    CLINICAL CANCER RESEARCH, 1999, 5 : 3787S - 3787S
  • [44] The role of determination of serum CA19-9 in evaluation of resectability of pancreatic cancer.
    Lee, HS
    Song, CW
    Um, SH
    Choi, JH
    Kim, CD
    Ryu, HS
    Hyun, JH
    GASTROENTEROLOGY, 1996, 110 (04) : A410 - A410
  • [45] Serum procarboxypeptidase combined with CAI9-9 and accuracy of detection of pancreatic cancer.
    Orlowski, Michelle A.
    Bamlet, William R.
    Oberg, Ann L.
    Petersen, Gloria M.
    Chari, Suresh T.
    Topilow, Arthur
    Davis, John
    Gilvarg, Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [46] Characterization of patients with high serum level of IL-6 in advanced pancreatic cancer.
    Miura, Tomofumi
    Mitsunaga, Shuichi
    Shimizu, Satoshi
    Ohno, Izumi
    Takahashi, Hideaki
    Okuyama, Hiroyuki
    Kuwahara, Akiko
    Ikeda, Masafumi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [47] A prospective evaluation of serum kynurenine metabolites and risk of pancreatic cancer
    Huang, Joyce Y.
    Butler, Lesley M.
    Midttun, Oivind
    Ulvik, Arve
    Wang, Renwei
    Jin, Aizhen
    Gao, Yu-Tang
    Ueland, Per M.
    Koh, Woon-Puay
    Yuan, Jian-Min
    PLOS ONE, 2018, 13 (05):
  • [48] Total Serum Cholesterol and Pancreatic Cancer Risk: What Is the Link?
    Mormile, Raffaella
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (02) : 1361 - 1361
  • [49] Kras mutation as a risk factor for venous thromboembolism in patients with metastatic pancreatic cancer.
    Serrano, Elena
    Inga Saavedra, Elizabeth
    Padilla Vico, Maria
    Perdomo, Eduardo
    Cano Osuna, Maria Teresa
    Toledano, Marta
    Aranda, Enrique
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [50] Prospective study of early detection of malignancies in individuals at risk for developing pancreatic cancer.
    Snyder, Courtney Edwards
    Haag, Susan
    Adams, Domenica
    Paskett, Breann
    Hess, Jade
    Borazanci, Erkut Hasan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
12345